Iressa more trouble for AstraZeneca AstraZeneca PLC #39;s shares plunged 7.7 percent Friday after a study found that its new lung-cancer drug Iressa failed to improve survival rates among patients. 

Which of the following sections of a newspaper would this article likely appear in? World News, Sports, Business, or Science and Technology? 